vs
微策略（MSTR）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
微策略的季度营收约是RIGEL PHARMACEUTICALS INC的1.8倍（$123.0M vs $69.8M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 1.9%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 3.3%）
Strategy Inc（原名为微策略）是1989年成立的美国上市企业，主营商业智能与移动软件业务，旗下产品可帮助企业分析内外部数据以支撑经营决策，还可用于移动应用开发，总部位于弗吉尼亚州泰森斯角，商业分析赛道核心竞品包括SAP等。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
MSTR vs RIGL — 直观对比
营收规模更大
MSTR
是对方的1.8倍
$69.8M
营收增速更快
RIGL
高出19.3%
1.9%
两年增速更快
RIGL
近两年复合增速
3.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $123.0M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | 66.1% | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 1.9% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | — | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MSTRRIGL
| Q4 25 | $123.0M | $69.8M | ||
| Q3 25 | $128.7M | $69.5M | ||
| Q2 25 | $114.5M | $101.7M | ||
| Q1 25 | $111.1M | $53.3M | ||
| Q4 24 | $120.7M | $57.6M | ||
| Q3 24 | $116.1M | $55.3M | ||
| Q2 24 | $111.4M | $36.8M | ||
| Q1 24 | $115.2M | $29.5M |
净利润MSTRRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $2.8B | $27.9M | ||
| Q2 25 | $10.0B | $59.6M | ||
| Q1 25 | $-4.2B | $11.4M | ||
| Q4 24 | $-670.8M | $14.3M | ||
| Q3 24 | $-340.2M | $12.4M | ||
| Q2 24 | $-102.6M | $-1.0M | ||
| Q1 24 | $-53.1M | $-8.2M |
毛利率MSTRRIGL
| Q4 25 | 66.1% | 91.5% | ||
| Q3 25 | 70.5% | 93.2% | ||
| Q2 25 | 68.8% | 95.6% | ||
| Q1 25 | 69.4% | 91.7% | ||
| Q4 24 | 71.7% | 89.9% | ||
| Q3 24 | 70.4% | 85.5% | ||
| Q2 24 | 72.2% | 92.4% | ||
| Q1 24 | 74.0% | 93.1% |
营业利润率MSTRRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 40.9% | ||
| Q2 25 | — | 60.1% | ||
| Q1 25 | -5331.4% | 23.9% | ||
| Q4 24 | -842.1% | 28.9% | ||
| Q3 24 | -372.7% | 25.4% | ||
| Q2 24 | -179.7% | 1.2% | ||
| Q1 24 | -176.8% | -23.6% |
净利率MSTRRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 2164.1% | 40.2% | ||
| Q2 25 | 8752.7% | 58.6% | ||
| Q1 25 | -3797.2% | 21.5% | ||
| Q4 24 | -555.8% | 24.9% | ||
| Q3 24 | -293.1% | 22.5% | ||
| Q2 24 | -92.0% | -2.8% | ||
| Q1 24 | -46.1% | -27.9% |
每股收益（稀释后）MSTRRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | $8.42 | $1.46 | ||
| Q2 25 | $32.60 | $3.28 | ||
| Q1 25 | $-16.49 | $0.63 | ||
| Q4 24 | $4.49 | $0.82 | ||
| Q3 24 | $-1.72 | $0.70 | ||
| Q2 24 | $-0.57 | $-0.06 | ||
| Q1 24 | $-0.31 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.3B | $155.0M |
| 总债务越低越好 | $8.2B | $52.5M |
| 股东权益账面价值 | $44.1B | $391.5M |
| 总资产 | $61.6B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.19× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资MSTRRIGL
| Q4 25 | $2.3B | $155.0M | ||
| Q3 25 | $54.3M | $137.1M | ||
| Q2 25 | $50.1M | $108.4M | ||
| Q1 25 | $60.3M | $77.1M | ||
| Q4 24 | $38.1M | $77.3M | ||
| Q3 24 | $46.3M | $61.1M | ||
| Q2 24 | $66.9M | $49.1M | ||
| Q1 24 | $81.3M | $49.5M |
总债务MSTRRIGL
| Q4 25 | $8.2B | $52.5M | ||
| Q3 25 | $8.2B | $60.0M | ||
| Q2 25 | $8.2B | $60.0M | ||
| Q1 25 | $8.1B | $60.0M | ||
| Q4 24 | $7.2B | $60.0M | ||
| Q3 24 | $4.2B | $60.0M | ||
| Q2 24 | $3.8B | $60.0M | ||
| Q1 24 | $3.6B | $60.0M |
股东权益MSTRRIGL
| Q4 25 | $44.1B | $391.5M | ||
| Q3 25 | $52.3B | $117.6M | ||
| Q2 25 | $47.5B | $81.9M | ||
| Q1 25 | $32.2B | $18.6M | ||
| Q4 24 | $18.2B | $3.3M | ||
| Q3 24 | $3.8B | $-14.6M | ||
| Q2 24 | $2.8B | $-29.9M | ||
| Q1 24 | $2.4B | $-31.7M |
总资产MSTRRIGL
| Q4 25 | $61.6B | $513.6M | ||
| Q3 25 | $73.6B | $242.5M | ||
| Q2 25 | $64.8B | $206.7M | ||
| Q1 25 | $43.9B | $176.0M | ||
| Q4 24 | $25.8B | $164.0M | ||
| Q3 24 | $8.3B | $139.4M | ||
| Q2 24 | $7.1B | $128.4M | ||
| Q1 24 | $6.4B | $126.5M |
负债/权益比MSTRRIGL
| Q4 25 | 0.19× | 0.13× | ||
| Q3 25 | 0.16× | 0.51× | ||
| Q2 25 | 0.17× | 0.73× | ||
| Q1 25 | 0.25× | 3.23× | ||
| Q4 24 | 0.39× | 18.25× | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.36× | — | ||
| Q1 24 | 1.48× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MSTRRIGL
| Q4 25 | — | $22.0M | ||
| Q3 25 | $-8.3M | $24.0M | ||
| Q2 25 | $-34.9M | $30.5M | ||
| Q1 25 | $-2.4M | $-893.0K | ||
| Q4 24 | $-17.3M | $14.5M | ||
| Q3 24 | $-41.0M | $21.7M | ||
| Q2 24 | $-23.3M | $302.0K | ||
| Q1 24 | $28.6M | $-5.0M |
自由现金流MSTRRIGL
| Q4 25 | — | — | ||
| Q3 25 | $-11.1M | — | ||
| Q2 25 | $-37.0M | — | ||
| Q1 25 | $-5.1M | — | ||
| Q4 24 | $-17.6M | — | ||
| Q3 24 | $-41.4M | — | ||
| Q2 24 | $-24.1M | — | ||
| Q1 24 | $27.0M | — |
自由现金流率MSTRRIGL
| Q4 25 | — | — | ||
| Q3 25 | -8.6% | — | ||
| Q2 25 | -32.3% | — | ||
| Q1 25 | -4.6% | — | ||
| Q4 24 | -14.6% | — | ||
| Q3 24 | -35.7% | — | ||
| Q2 24 | -21.6% | — | ||
| Q1 24 | 23.5% | — |
资本支出强度MSTRRIGL
| Q4 25 | — | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 1.3% | — |
现金转化率MSTRRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | -0.00× | 0.86× | ||
| Q2 25 | -0.00× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
